TEL AVIV, Israel, March 18, 2018 /PRNewswire/ -- MedyMatch
Technology, a company focused on assisting physicians provide
accurate patient assessment through artificial intelligence-based
insights, (which recently received FDA Breakthrough Designation for
its intracranial hemorrhage (ICH) detection application), announced
today an exciting new phase in its growth with the launch of its
new corporate identity as MaxQ-AI.
"Today we launch the MaxQ-AI brand to reflect a new day in the
company's journey in bringing artificial intelligence based
clinical applications to the marketplace," said Gene
Saragnese, Chairman & CEO of MaxQ-AI. "The healthcare
industry is at an inflection point, at a "Max Q" (a point of
maximum pressure) – we believe AI has the potential to
fundamentally reinvent healthcare as we know it, to deliver
accurate and cost-effective patient care to billions of people
around the world."
MaxQ-AI has developed a broad machine vision and deep learning
platform to support the assessment of multiple clinical
indications. The Company's team of AI, deep learning and machine
vision experts are working with world-class clinical and industry
partners to yield unprecedented insights into medical
data. The first of these applications will be the detection of
intracranial hemorrhage. Accurate and timely detection of ICH is a
critical step in clinical decision making for stroke assessment and
head trauma. Working with its development and distribution
partners, MaxQ-AI is on a mission to make all caregivers confident,
life-saving experts every time and in all locations through
AI-enabled clinical decision support at the point of care.
About MaxQ-AI
Formerly known as MedyMatch Technology,
based in Tel Aviv, Israel, MaxQ-AI
is a leading medical artificial intelligence company delivering a
clinical decision support platform to improve patient outcomes in
acute medical scenarios. The platform can be natively integrated
into PACS systems, medical imaging hardware or healthcare clouds.
To learn more, please visit http://maxq.ai.
Press Contacts:
Michael
Rosenberg
Chief Commercial & Financial Officer
MaxQ-AI Ltd.
press@maxq.ai
View original content with
multimedia:http://www.prnewswire.com/news-releases/medymatch-technology-announces-name-change-to-maxq-ai-300615658.html
SOURCE MedyMatch Technology